Multiple-dose safety study of ibuprofen/codeine and aspirin/codeine combinations

Area of Science:

• Pharmacology
• Clinical Safety Studies

Background:

• Opioid and non-opioid analgesic combinations are widely used for pain management.
• Understanding the comparative safety profiles of different formulations is crucial for clinical practice.

Purpose of the Study:

• To compare the systemic safety of ibuprofen/codeine versus aspirin/codeine formulations.
• To evaluate adverse effects on vital signs, hematologic, biochemical, and urinary parameters, mood, and mental alertness.

Main Methods:

• Multiple-dose, double-blind, placebo-controlled, randomized study in normal volunteers.
• Monitoring of vital signs, laboratory parameters, side effects, mood, and mental alertness.
• Comparison between ibuprofen/codeine, aspirin/codeine, and placebo groups.

Main Results:

• Aspirin/codeine demonstrated greater adverse effects on mood and mental alertness compared to ibuprofen/codeine and placebo.
• Ibuprofen/codeine exhibited a more favorable adverse effect profile than aspirin/codeine.
• Mild respiratory and cardiac depressant effects attributed to codeine were observed in active treatment groups after 7 days.

Conclusions:

• Ibuprofen/codeine presents a more favorable safety profile than aspirin/codeine.
• Codeine, in both formulations, can cause mild respiratory and cardiac depression with frequent, prolonged use.
• Further research is needed to understand tolerance development to opioid depressant effects.